back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-12-04 16:04 Tx date 2024-12-04 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-200,000 vol |
700,000 | |
| Filed 2024-12-04 16:02 Tx date 2024-12-04 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
58 - Expiration of rights
|
-150,000 vol |
0 | |
| Filed 2024-12-04 15:59 Tx date 2024-12-04 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-600,000 vol |
3,234,000 | |
| Filed 2024-12-04 15:38 Tx date 2024-12-04 |
$MLCL
Molecule Holdings Inc. |
Weatherdon, Lindsay Thomas
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-150,000 vol |
646,500 | |
| Filed 2024-12-03 18:26 Tx date 2024-11-28 |
$MLCL
Molecule Holdings Inc. |
Weatherdon, Lindsay Thomas
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+646,500 vol |
796,500 | |
| Filed 2024-12-03 18:23 Tx date 2024-11-28 |
$MLCL
Molecule Holdings Inc. |
Weatherdon, Lindsay Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$32,325
+1,616,250 vol $0.02 each |
2,616,250 | |
| Filed 2024-12-03 18:21 Tx date 2024-11-28 |
$MLCL
Molecule Holdings Inc. |
Weatherdon, Lindsay Thomas
4 - Director of Issuer
Direct Ownership
|
Debentures Unsecured Convertible July 2021
36 - Conversion or exchange
|
$
-$25 vol $0.02 each |
$0 | |
| Filed 2024-12-03 16:00 Tx date 2024-11-28 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+3,234,000 vol |
3,834,000 | |
| Filed 2024-12-03 15:58 Tx date 2024-11-28 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$161,700
+8,085,000 vol $0.02 each |
17,543,170 | |
| Filed 2024-12-03 15:56 Tx date 2024-11-28 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
8% Convertible Debentures
36 - Conversion or exchange
|
$-0.50
-25 vol $0.02 each |
0 | |
| Filed 2024-12-03 15:55 Tx date 2024-11-28 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Debentures Unsecured Convertible July 2021
36 - Conversion or exchange
|
$
-$100 vol $0.02 each |
$0 | |
| Filed 2024-12-03 15:47 Tx date 2024-11-28 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+1,296,000 vol |
1,296,000 | |
| Filed 2024-12-03 15:45 Tx date 2020-09-16 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-12-03 15:44 Tx date 2024-11-28 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$64,800
+3,240,000 vol $0.02 each |
5,077,500 | |
| Filed 2024-12-03 15:42 Tx date 2024-11-28 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
8% Convertible Debentures
36 - Conversion or exchange
|
$-1.00
-50 vol $0.02 each |
0 | |
| Filed 2024-12-03 15:39 Tx date 2020-09-16 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-12-03 15:37 Tx date 2020-09-16 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
400,000 | ||
| Filed 2024-12-03 15:36 Tx date 2024-11-28 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+259,200 vol |
259,200 | |
| Filed 2024-12-03 15:33 Tx date 2020-09-16 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-12-03 15:32 Tx date 2024-11-28 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$12,960
+648,000 vol $0.02 each |
3,085,500 | |
| Filed 2024-12-03 15:30 Tx date 2020-09-16 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,437,500 | ||
| Filed 2024-12-03 15:26 Tx date 2020-09-16 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
8% Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-21 15:38 Tx date 2022-10-20 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+250,000 vol $0.04 each |
9,458,170 | |
| Filed 2022-10-21 15:35 Tx date 2022-09-21 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
56 - Grant of rights
|
+3,000,000 vol |
3,000,000 | |
| Filed 2022-03-18 16:28 Tx date 2022-03-16 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,460
+76,000 vol $0.085 each |
9,208,170 | |
| Filed 2022-02-17 10:52 Tx date 2022-02-15 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,000
+100,000 vol $0.08 each |
9,132,170 | |
| Filed 2022-02-17 10:51 Tx date 2022-02-15 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,000
+100,000 vol $0.08 each |
9,032,170 | |
| Filed 2021-12-06 12:37 Tx date 2021-12-02 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,300
+90,000 vol $0.07 each |
8,932,170 | |
| Filed 2021-11-15 12:26 Tx date 2021-11-10 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,000
+200,000 vol $0.055 each |
8,842,170 | |
| Filed 2021-09-14 08:34 Tx date 2021-06-30 |
$MLCL
Molecule Holdings Inc. |
Stoss, Jeffrey
5 - Senior Officer of Issuer
Holder: Positive Venture Group Inc. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$8,906
+93,750 vol $0.095 each |
187,500 | |
| Filed 2021-09-14 08:29 Tx date 2021-06-30 |
$MLCL
Molecule Holdings Inc. |
Stoss, Jeffrey
5 - Senior Officer of Issuer
Holder: Positive Venture Group Inc. (Indirect Ownership)
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-93,750 vol |
0 | |
| Filed 2021-08-16 21:25 Tx date 2021-07-30 |
$MLCL
Molecule Holdings Inc. |
Weatherdon, Lindsay Thomas
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+150,000 vol |
150,000 | |
| Filed 2021-08-16 21:24 Tx date 2020-09-16 |
$MLCL
Molecule Holdings Inc. |
Weatherdon, Lindsay Thomas
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-16 21:23 Tx date 2021-07-30 |
$MLCL
Molecule Holdings Inc. |
Weatherdon, Lindsay Thomas
4 - Director of Issuer
Direct Ownership
|
Debentures Unsecured Convertible July 2021
16 - Acquisition or disposition under a prospectus exemption
|
$
+$25 vol $1,000 each |
$25 | |
| Filed 2021-08-16 21:21 Tx date 2021-07-30 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+600,000 vol |
600,000 | |
| Filed 2021-08-16 21:17 Tx date 2021-07-30 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Debentures Unsecured Convertible July 2021
16 - Acquisition or disposition under a prospectus exemption
|
$
+$100 vol $1,000 each |
$100 | |
| Filed 2021-08-05 16:22 Tx date 2021-07-30 |
$MLCL
Molecule Holdings Inc. |
Weatherdon, Lindsay Thomas
4 - Director of Issuer
Direct Ownership
|
Debentures Unsecured Convertible July 2021
16 - Acquisition or disposition under a prospectus exemption
|
$
+$25 vol $0.10 each |
||
| Filed 2021-08-05 16:20 Tx date 2021-07-30 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Debentures Unsecured Convertible July 2021
16 - Acquisition or disposition under a prospectus exemption
|
$
+$100 vol $0.10 each |
||
| Filed 2021-08-05 16:22 Tx date 2021-07-30 |
$MLCL
Molecule Holdings Inc. |
Weatherdon, Lindsay Thomas
4 - Director of Issuer
Direct Ownership
|
Debentures Unsecured Convertible July 2021
16 - Acquisition or disposition under a prospectus exemption
|
$
+$25 vol $0.10 each |
$25 | |
| Filed 2021-08-05 16:21 Tx date 2020-09-16 |
$MLCL
Molecule Holdings Inc. |
Weatherdon, Lindsay Thomas
4 - Director of Issuer
Direct Ownership
|
Debentures Unsecured Convertible July 2021
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-05 16:20 Tx date 2021-07-30 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Debentures Unsecured Convertible July 2021
16 - Acquisition or disposition under a prospectus exemption
|
$
+$100 vol $0.10 each |
$100 | |
| Filed 2021-08-05 16:18 Tx date 2003-07-01 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Debentures Unsecured Convertible July 2021
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-01 16:25 Tx date 2021-07-27 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+50,000 vol $0.08 each |
8,642,170 | |
| Filed 2021-06-06 22:38 Tx date 2021-06-01 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+62,500 vol |
2,437,500 | |
| Filed 2021-06-06 22:38 Tx date 2021-06-01 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-62,500 vol |
187,500 | |
| Filed 2021-06-06 22:35 Tx date 2021-06-01 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+62,500 vol |
8,592,170 | |
| Filed 2021-06-06 22:34 Tx date 2021-06-01 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-62,500 vol |
150,000 | |
| Filed 2021-06-06 22:32 Tx date 2021-06-01 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+125,000 vol |
1,837,500 | |
| Filed 2021-06-06 22:31 Tx date 2021-06-01 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-125,000 vol |
0 | |
| Filed 2021-04-07 14:59 Tx date 2021-03-31 |
$MLCL
Molecule Holdings Inc. |
Stoss, Jeffrey
5 - Senior Officer of Issuer
Holder: Positive Venture Group Inc. (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
$10,312
+93,750 vol $0.11 each |
93,750 | |
| Filed 2021-04-07 14:56 Tx date 2021-03-31 |
$MLCL
Molecule Holdings Inc. |
Stoss, Jeffrey
5 - Senior Officer of Issuer
Holder: Positive Venture Group Inc. (Control or Direction)
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-93,750 vol |
93,750 | |
| Filed 2021-04-05 09:20 Tx date 2021-03-31 |
$MLCL
Molecule Holdings Inc. |
Stoss, Jeffrey
5 - Senior Officer of Issuer
Holder: Positive Venture Group Inc. (Control or Direction)
|
Common Shares
58 - Expiration of rights
|
$10,312
+93,750 vol $0.11 each |
||
| Filed 2021-04-05 09:17 Tx date 2021-03-31 |
$MLCL
Molecule Holdings Inc. |
Stoss, Jeffrey
5 - Senior Officer of Issuer
Holder: Positive Venture Group Inc. (Control or Direction)
|
Restricted Share Units (Molecule)
58 - Expiration of rights
|
-93,750 vol |
||
| Filed 2021-04-05 09:20 Tx date 2021-03-31 |
$MLCL
Molecule Holdings Inc. |
Stoss, Jeffrey
5 - Senior Officer of Issuer
Holder: Positive Venture Group Inc. (Control or Direction)
|
Common Shares
58 - Expiration of rights
|
$10,312
+93,750 vol $0.11 each |
93,750 | |
| Filed 2021-04-05 09:19 Tx date 2020-11-10 |
$MLCL
Molecule Holdings Inc. |
Stoss, Jeffrey
5 - Senior Officer of Issuer
Holder: Positive Venture Group Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-05 09:17 Tx date 2021-03-31 |
$MLCL
Molecule Holdings Inc. |
Stoss, Jeffrey
5 - Senior Officer of Issuer
Holder: Positive Venture Group Inc. (Control or Direction)
|
Restricted Share Units (Molecule)
58 - Expiration of rights
|
-93,750 vol |
93,750 | |
| Filed 2021-04-04 21:08 Tx date 2021-03-31 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+150,000 vol |
8,529,670 | |
| Filed 2021-04-04 21:07 Tx date 2021-03-31 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-150,000 vol |
212,500 | |
| Filed 2021-04-04 21:05 Tx date 2021-03-31 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+187,500 vol |
2,375,000 | |
| Filed 2021-04-04 21:05 Tx date 2021-03-31 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-187,500 vol |
250,000 | |
| Filed 2021-03-04 21:48 Tx date 2021-03-01 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+125,000 vol |
1,712,500 | |
| Filed 2021-03-04 21:48 Tx date 2021-03-01 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-125,000 vol |
125,000 | |
| Filed 2021-03-04 21:46 Tx date 2021-03-01 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+62,500 vol |
8,379,670 | |
| Filed 2021-03-04 21:46 Tx date 2021-03-01 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-62,500 vol |
362,500 | |
| Filed 2021-03-04 21:44 Tx date 2021-03-01 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+62,500 vol |
2,187,500 | |
| Filed 2021-03-04 21:44 Tx date 2021-03-01 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-62,500 vol |
437,500 | |
| Filed 2021-02-12 20:46 Tx date 2021-02-08 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
700,000 | |
| Filed 2021-02-12 20:45 Tx date 2021-02-08 |
$MLCL
Molecule Holdings Inc. |
Weatherdon, Lindsay Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
400,000 | |
| Filed 2021-02-12 20:44 Tx date 2020-09-16 |
$MLCL
Molecule Holdings Inc. |
Weatherdon, Lindsay Thomas
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-12 20:42 Tx date 2021-02-08 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
||
| Filed 2021-02-12 20:40 Tx date 2021-02-08 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
||
| Filed 2021-02-12 20:37 Tx date 2021-02-08 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
900,000 | |
| Filed 2021-02-12 20:36 Tx date 2021-02-08 |
$MLCL
Molecule Holdings Inc. |
Proulx, Amy Katheryn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
400,000 | |
| Filed 2021-02-12 20:35 Tx date 2020-09-16 |
$MLCL
Molecule Holdings Inc. |
Proulx, Amy Katheryn
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-12 20:34 Tx date 2021-02-08 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
400,000 | |
| Filed 2021-02-12 20:33 Tx date 2020-09-16 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-08 22:40 Tx date 2021-02-05 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,000
+100,000 vol $0.13 each |
8,317,170 | |
| Filed 2021-02-03 09:22 Tx date 2021-01-29 |
$MLCL
Molecule Holdings Inc. |
Stoss, Jeffrey
5 - Senior Officer of Issuer
Holder: Positive Venture Group Inc. (Control or Direction)
|
Restricted Share Units (Molecule)
56 - Grant of rights
|
+187,500 vol |
187,500 | |
| Filed 2021-02-03 09:15 Tx date 2020-11-10 |
$MLCL
Molecule Holdings Inc. |
Stoss, Jeffrey
5 - Senior Officer of Issuer
Holder: Positive Venture Group Inc. (Control or Direction)
|
Restricted Share Units (Molecule)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-02 23:15 Tx date 2021-01-29 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
56 - Grant of rights
|
+375,000 vol |
500,000 | |
| Filed 2021-02-02 23:13 Tx date 2021-01-29 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$34,999
+233,333 vol $0.15 each |
8,217,170 | |
| Filed 2021-02-02 23:12 Tx date 2021-01-29 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+204,167 vol |
7,983,837 | |
| Filed 2021-02-02 23:11 Tx date 2021-01-29 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-204,167 vol |
425,000 | |
| Filed 2021-02-02 23:11 Tx date 2021-01-29 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
56 - Grant of rights
|
+504,167 vol |
629,167 | |
| Filed 2021-02-02 23:08 Tx date 2021-01-29 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-612,500 vol |
250,000 | |
| Filed 2021-02-02 23:07 Tx date 2021-01-29 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
56 - Grant of rights
|
+612,500 vol |
862,500 | |
| Filed 2021-02-02 23:06 Tx date 2021-01-29 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+612,500 vol |
1,562,500 | |
| Filed 2021-02-02 23:05 Tx date 2021-01-29 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$105,000
+700,000 vol $0.15 each |
950,000 | |
| Filed 2021-02-02 23:04 Tx date 2021-02-02 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,250
+25,000 vol $0.13 each |
1,587,500 | |
| Filed 2020-12-22 20:38 Tx date 2020-12-01 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+125,000 vol |
250,000 | |
| Filed 2020-12-22 20:38 Tx date 2020-12-01 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-125,000 vol |
250,000 | |
| Filed 2020-12-22 20:36 Tx date 2020-12-01 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+62,500 vol |
2,125,000 | |
| Filed 2020-12-22 20:36 Tx date 2020-12-01 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-62,500 vol |
125,000 | |
| Filed 2020-12-22 20:03 Tx date 2020-12-01 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+62,500 vol |
7,779,670 | |
| Filed 2020-12-22 20:02 Tx date 2020-12-01 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-62,500 vol |
125,000 | |
| Filed 2020-10-31 19:49 Tx date 2020-10-27 |
$MLCL
Molecule Holdings Inc. |
Stutt, Brendan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,500
+50,000 vol $0.07 each |
325,000 | |
| Filed 2020-10-31 19:49 Tx date 2020-10-27 |
$MLCL
Molecule Holdings Inc. |
Stutt, Brendan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+50,000 vol $0.08 each |
275,000 | |
| Filed 2020-10-05 13:38 Tx date 2020-10-01 |
$MLCL
Molecule Holdings Inc. |
Stutt, Brendan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,500
+100,000 vol $0.075 each |
225,000 | |
| Filed 2020-09-30 19:04 Tx date 2020-09-25 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,000
+100,000 vol $0.07 each |
7,717,170 | |
| Filed 2020-09-22 22:28 Tx date 2020-09-18 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+125,000 vol |
125,000 | |
| Filed 2020-09-22 22:28 Tx date 2020-09-16 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-22 22:28 Tx date 2020-09-18 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-125,000 vol |
375,000 | |
| Filed 2020-09-22 22:25 Tx date 2020-09-18 |
$MLCL
Molecule Holdings Inc. |
Stutt, Brendan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+125,000 vol |
125,000 | |
| Filed 2020-09-22 22:24 Tx date 2019-03-01 |
$MLCL
Molecule Holdings Inc. |
Stutt, Brendan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-22 22:24 Tx date 2020-09-18 |
$MLCL
Molecule Holdings Inc. |
Stutt, Brendan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-125,000 vol |
375,000 | |
| Filed 2020-09-22 22:22 Tx date 2020-09-18 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+62,500 vol |
7,617,170 | |
| Filed 2020-09-22 22:21 Tx date 2020-09-18 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-62,500 vol |
187,500 | |
| Filed 2020-09-22 22:16 Tx date 2020-09-18 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+62,500 vol |
2,062,500 | |
| Filed 2020-09-22 22:15 Tx date 2020-09-18 |
$MLCL
Molecule Holdings Inc. |
Waddington, Philip
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-62,500 vol |
187,500 | |
| Filed 2020-09-22 01:32 Tx date 2020-09-18 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,900
+30,000 vol $0.13 each |
7,554,670 | |
| Filed 2020-09-22 01:27 Tx date 2020-09-17 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+10,000 vol $0.20 each |
7,524,670 | |
| Filed 2020-09-22 01:26 Tx date 2020-09-17 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,500
+10,000 vol $0.15 each |
7,514,670 | |
| Filed 2020-09-22 01:25 Tx date 2020-09-17 |
$MLCL
Molecule Holdings Inc. |
Audet, André
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,000
+100,000 vol $0.08 each |
7,504,670 |